• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Elevated C-reactive protein is associated with shortened leukemia-free survival in patients with myelofibrosis.

作者信息

Barbui T, Carobbio A, Finazzi G, Guglielmelli P, Salmoiraghi S, Rosti V, Rambaldi A, Vannucchi A M, Barosi G

机构信息

1] Fondazione per la Ricerca Ospedale Maggiore (FROM), Ospedale Papa Giovanni XXIII, Bergamo, Italy [2] Divisione di Ematologia, Ospedale Papa Giovanni XXIII, Bergamo, Italy.

出版信息

Leukemia. 2013 Oct;27(10):2084-6. doi: 10.1038/leu.2013.207. Epub 2013 Jul 5.

DOI:10.1038/leu.2013.207
PMID:23828261
Abstract
摘要

相似文献

1
Elevated C-reactive protein is associated with shortened leukemia-free survival in patients with myelofibrosis.C反应蛋白升高与骨髓纤维化患者无白血病生存期缩短有关。
Leukemia. 2013 Oct;27(10):2084-6. doi: 10.1038/leu.2013.207. Epub 2013 Jul 5.
2
Leukemia risk models in primary myelofibrosis: an International Working Group study.原发性骨髓纤维化的白血病风险模型：一项国际工作组研究。
Leukemia. 2012 Jun;26(6):1439-41. doi: 10.1038/leu.2011.374. Epub 2012 Jan 13.
3
Clinical significance of pretreatment serum C-reactive protein level in soft tissue sarcoma.软组织肉瘤患者治疗前血清 C 反应蛋白水平的临床意义。
Cancer. 2012 Feb 15;118(4):1055-61. doi: 10.1002/cncr.26353. Epub 2011 Jul 14.
4
Is C-reactive protein a prognostic factor of colorectal cancer?C反应蛋白是结直肠癌的一个预后因素吗？
Dis Colon Rectum. 2008 Apr;51(4):443-9. doi: 10.1007/s10350-007-9133-z. Epub 2008 Jan 3.
5
Polyclonal immunoglobulin free light chain levels predict survival in myeloid neoplasms.多克隆免疫球蛋白游离轻链水平可预测髓系肿瘤的生存情况。
J Clin Oncol. 2012 Apr 1;30(10):1087-94. doi: 10.1200/JCO.2011.39.0310. Epub 2012 Feb 13.
6
Plasma cytokines in polycythemia vera: phenotypic correlates, prognostic relevance, and comparison with myelofibrosis.真性红细胞增多症患者血浆细胞因子：表型相关性、预后相关性及与骨髓纤维化的比较。
Am J Hematol. 2012 Nov;87(11):1003-5. doi: 10.1002/ajh.23295. Epub 2012 Sep 11.
7
De novo appearance of der(1;7)(q10;p10) is associated with leukemic transformation and unfavorable prognosis in essential thrombocythemia.新发的der(1;7)(q10;p10)与原发性血小板增多症的白血病转化及不良预后相关。
Leuk Res. 2005 Nov;29(11):1247-52. doi: 10.1016/j.leukres.2005.03.011. Epub 2005 Apr 14.
8
Primary myelofibrosis with or without mutant MPL: comparison of survival and clinical features involving 603 patients.原发性骨髓纤维化伴或不伴突变 MPL：603 例患者生存和临床特征的比较。
Leukemia. 2011 Dec;25(12):1834-9. doi: 10.1038/leu.2011.161. Epub 2011 Jun 21.
9
Long term follow up of 93 families with myeloproliferative neoplasms: life expectancy and implications of JAK2V617F in the occurrence of complications.93 个骨髓增殖性肿瘤家系的长期随访：预期寿命和 JAK2V617F 在并发症发生中的意义。
Blood Cells Mol Dis. 2012;49(3-4):170-6. doi: 10.1016/j.bcmd.2012.06.004. Epub 2012 Jul 19.
10
Risk stratification in oral cavity squamous cell carcinoma by preoperative CRP and SCC antigen levels.术前 CRP 和 SCC 抗原水平在口腔鳞状细胞癌中的风险分层。
Ann Surg Oncol. 2012 Nov;19(12):3856-64. doi: 10.1245/s10434-012-2392-5. Epub 2012 May 11.

引用本文的文献

1
Intersecting Pathways: The Impact of Philadelphia-Negative Chronic Myeloproliferative Neoplasms on the Pathogenesis and Progression of Heart Failure with Preserved Ejection Fraction.交叉途径：费城染色体阴性慢性骨髓增殖性肿瘤对射血分数保留的心力衰竭发病机制和进展的影响
Diagnostics (Basel). 2025 Aug 14;15(16):2042. doi: 10.3390/diagnostics15162042.
2
Red Blood Cell Distribution Width May Predict Drug-Induced Anemia and Prognosis in Patients Affected by Primary/Secondary Myelofibrosis Treated with Ruxolitinib.红细胞分布宽度可能预测接受鲁索替尼治疗的原发性/继发性骨髓纤维化患者的药物性贫血及预后。
Oncol Ther. 2025 Mar;13(1):165-183. doi: 10.1007/s40487-024-00322-2. Epub 2025 Jan 17.
3
Clinical features and treatment of newly diagnosed multiple myeloma with secondary myelofibrosis: a retrospective study.
新诊断的伴继发性骨髓纤维化的多发性骨髓瘤的临床特征与治疗：一项回顾性研究
Ther Adv Hematol. 2024 Oct 28;15:20406207241292453. doi: 10.1177/20406207241292453. eCollection 2024.
4
Thrombosis in myeloproliferative neoplasms: a viewpoint on its impact on myelofibrosis, mortality, and solid tumors.骨髓增殖性肿瘤中的血栓形成：对其影响骨髓纤维化、死亡率和实体瘤的观点。
Blood Cancer J. 2024 Oct 25;14(1):188. doi: 10.1038/s41408-024-01169-6.
5
Circulating Polymorphonuclear Myeloid-Derived Suppressor Cells (PMN-MDSCs) Have a Biological Role in Patients with Primary Myelofibrosis.循环多形核髓系来源抑制细胞（PMN-MDSCs）在原发性骨髓纤维化患者中具有生物学作用。
Cancers (Basel). 2024 Jul 16;16(14):2556. doi: 10.3390/cancers16142556.
6
The use of the ratio of C-reactive protein to albumin for the diagnosis of pediatric septic arthritis.使用C反应蛋白与白蛋白的比值诊断小儿化脓性关节炎。
Front Pediatr. 2024 Jan 16;11:1308513. doi: 10.3389/fped.2023.1308513. eCollection 2023.
7
Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms.重新审视循环细胞外基质片段作为骨髓纤维化及相关肿瘤的疾病标志物
Cancers (Basel). 2023 Aug 29;15(17):4323. doi: 10.3390/cancers15174323.
8
Systemic inflammatory indices for predicting prognosis of myelofibrosis.系统性炎症指标预测骨髓纤维化预后。
Sci Rep. 2023 Aug 2;13(1):12539. doi: 10.1038/s41598-023-39077-7.
9
CRP/Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70-A Retrospective Study.CRP/白蛋白比值和格拉斯哥预后评分在骨髓纤维化中独立于MIPSS70-A提供预后信息：一项回顾性研究
Cancers (Basel). 2023 Feb 25;15(5):1479. doi: 10.3390/cancers15051479.
10
Significance of C-reactive protein in patients with chronic myelomonocytic leukemia.C 反应蛋白在慢性粒单核细胞白血病患者中的意义。
Wien Med Wochenschr. 2023 Feb;173(1-2):15-20. doi: 10.1007/s10354-022-00981-8. Epub 2022 Nov 28.